NovaBridge Biosciences: cost_of_revenue
| Value | {"amount": 7286000, "concept": "us-gaap:CostOfRevenue", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a79e83f3-062b-487c-baac-75cbdb215ec9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-22-133550Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/cost-of-revenue/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a79e83f3-062b-487c-baac-75cbdb215ec9
History
- supersedes {"unit": "CNY", "value": 46432000, "concept": "us-gaap:CostOfRevenue"} (evidence 0001193125-22-133550)